Herbert Opitz

1.7k citations
9 papers · 1.4k · 1 hit paper · h-index 8

Impact in

  • Genetics top 2%
    • Hemoglobinopathies and Related Disorders
  • Hematology top 2%
    • Iron Metabolism and Disorders
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Platelet Disorders and Treatments

Papers in

    • Hemoglobinopathies and Related Disorders 8
    • Iron Metabolism and Disorders 2
    • Platelet Disorders and Treatments 1

Herbert Opitz

9 papers receiving 1.3k citations

Herbert Opitz's Hit Papers

A novel mechanism of sustained platelet aIIbB3 activation via PEAR1 2003 · 963 citations
9630+7+15Years since publication250500750

Peers

Herbert Opitz
Comparison fields: 5 of 98
  • Genetics 393
  • Hematology 448
  • Immunology 96
  • Pathology and Forensic Medicine 78
  • Oncology 89
Replace Mark Myers Udden with:
Mark Myers Udden United States
Hélène Jouault France
Claudio Fozza Italy
Vaishali Sanchorawala United States
Abhishek Avinash Mangaonkar United States
Uri Rozovski Israel
Philippe Travade France
Silvia Giannini Italy
Fabio Stagno Italy
Leonard T. Heffner United States
Herbert Opitz relative to Mark Myers Udden United States Mark Myers Udden's profile →
Citations per field
00.5×5×10.6×
Mark Myers Udden · 1×
Citations per year

Countries citing papers authored by Herbert Opitz

Since Specialization
Citations

This map shows the geographic impact of Herbert Opitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Opitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Opitz more than expected).

Fields of papers citing papers by Herbert Opitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Opitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Opitz. The network helps show where Herbert Opitz may publish in the future.

Co-authors

The 25 scholars most cited alongside Herbert Opitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Herbert Opitz Line = papers co-authored together Herbert Opitz links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
A novel mechanism of sustained platelet aIIbB3 activation via PEAR1
Hit paper breakdown →
2003963
2
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
2006241
3 2007106
4 200518
5 200512
6 200510
7 20059
8 20048
9 20057

About Herbert Opitz

Herbert Opitz is a scholar working on Genetics, Hematology, Immunology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (2 papers), T-cell and B-cell Immunology (1 paper), Platelet Disorders and Treatments (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Genetics (393 citations), Hematology (448 citations), Immunology (96 citations), Pathology and Forensic Medicine (78 citations) and Oncology (89 citations). Herbert Opitz has collaborated with scholars based in Switzerland, Italy and Germany. Frequent co-authors include J. Ford, Maria Domenica Cappellini, Antonietta Zappu, Nicola Hewson, Antonio Giulio Piga, Raffaella Origa, Renzo Galanello, Antonella Lavagetto, Laura Zanaboni and Daniele Alberti. Their work appears in journals such as Blood, Clinical Therapeutics, eCite Digital Repository (University of Tasmania) and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact